These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 2120204)

  • 21. Treatment of adolescent obsessive-compulsive disorder with a clomipramine-fluoxetine combination.
    Simeon JG; Thatte S; Wiggins D
    Psychopharmacol Bull; 1990; 26(3):285-90. PubMed ID: 2274627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacologic management of obsessive-compulsive disorder.
    Jackson CW; Morton WA; Lydiard RB
    South Med J; 1994 Mar; 87(3):310-21. PubMed ID: 8134850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Obsessive-compulsive disorder.
    George MS
    Int Clin Psychopharmacol; 1991 Dec; 6 Suppl 3():57-66; discussion 66-8. PubMed ID: 1806635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacotherapy of childhood obsessive-compulsive disorder.
    Leonard HL; Rapoport JL
    Psychiatr Clin North Am; 1989 Dec; 12(4):963-70. PubMed ID: 2690035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A controlled trial of lithium augmentation in fluvoxamine-refractory obsessive-compulsive disorder: lack of efficacy.
    McDougle CJ; Price LH; Goodman WK; Charney DS; Heninger GR
    J Clin Psychopharmacol; 1991 Jun; 11(3):175-84. PubMed ID: 1820757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive value of obsessive-compulsive personality disorder in antiobsessional pharmacological treatment.
    Cavedini P; Erzegovesi S; Ronchi P; Bellodi L
    Eur Neuropsychopharmacol; 1997 Feb; 7(1):45-9. PubMed ID: 9088884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Obsessive-compulsive disorder: a new perspective in diagnosis and treatment.
    Lydiard RB
    Int Clin Psychopharmacol; 1994 Jun; 9 Suppl 3():33-7. PubMed ID: 7963449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are effective antiobsessional drugs interchangeable?
    Tamimi RR; Mavissakalian MR
    Arch Gen Psychiatry; 1991 Sep; 48(9):857-9. PubMed ID: 1929778
    [No Abstract]   [Full Text] [Related]  

  • 29. Obsessive-compulsive disorder.
    Zetin M; Kramer MA
    Hosp Community Psychiatry; 1992 Jul; 43(7):689-99. PubMed ID: 1516899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacotherapy of obsessive-compulsive disorder.
    Jermain DM; Crismon ML
    Pharmacotherapy; 1990; 10(3):175-98. PubMed ID: 2196535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Obsessive compulsive disorder.
    J Clin Psychiatry; 1989 Jun; 50(6):231-2. PubMed ID: 2498297
    [No Abstract]   [Full Text] [Related]  

  • 32. Tricyclic antidepressants in obsessive-compulsive disorder: antiobsessional or antidepressant agents? II.
    Mavissakalian M; Turner SM; Michelson L; Jacob R
    Am J Psychiatry; 1985 May; 142(5):572-6. PubMed ID: 3885761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serotonin and treatment in obsessive-compulsive disorder.
    March JS; Gutzman LD; Jefferson JW; Greist JH
    Psychiatr Dev; 1989; 7(1):1-18. PubMed ID: 2508084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Obsessive-compulsive disorder.
    March JS; Johnston H; Greist JH
    Am Fam Physician; 1989 May; 39(5):175-82. PubMed ID: 2497627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder.
    McDougle CJ; Goodman WK; Leckman JF; Barr LC; Heninger GR; Price LH
    J Clin Psychopharmacol; 1993 Oct; 13(5):354-8. PubMed ID: 8227493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder.
    Foa EB; Liebowitz MR; Kozak MJ; Davies S; Campeas R; Franklin ME; Huppert JD; Kjernisted K; Rowan V; Schmidt AB; Simpson HB; Tu X
    Am J Psychiatry; 2005 Jan; 162(1):151-61. PubMed ID: 15625214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serotonergic antidepressants and their efficacy in obsessive compulsive disorder.
    Dominguez RA
    J Clin Psychiatry; 1992 Oct; 53 Suppl():56-9. PubMed ID: 1429485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine.
    Goodman WK; Price LH; Delgado PL; Palumbo J; Krystal JH; Nagy LM; Rasmussen SA; Heninger GR; Charney DS
    Arch Gen Psychiatry; 1990 Jun; 47(6):577-85. PubMed ID: 2112374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of obsessive compulsive disorder: psychotherapies, drugs, and other somatic treatment.
    Greist JH
    J Clin Psychiatry; 1990 Aug; 51 Suppl():44-50; discussion 55-8. PubMed ID: 2116405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Refining treatment approaches in obsessive-compulsive disorder.
    Fineberg N
    Int Clin Psychopharmacol; 1996 Dec; 11 Suppl 5():13-22. PubMed ID: 9032000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.